Posted by Michael Wonder on 09 Feb 2022
FDA raises concerns about China developed drugs
9 February 2022 - Agency could slow the plans of big Western drugmakers to sell Chinese tested medicines in U.S.
U.S. regulators are poised to tap the brakes on approving dozens of cancer drugs and other new medicines developed in China.
The regulators have expressed concerns about the quality of studies largely conducted in China and whether the results can apply to patients in the U.S.
